70511-131 : Sincalide 5 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: | 70511-131 |
Labeler: | Maia Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Sincalide |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
Application #: | NDA210850 |
Rev. Date: |
NDC Package Codes:
- 70511-131-84: 10 VIAL IN 1 PACKAGE (70511‑131‑84) > 5 ML IN 1 VIAL (70511‑131‑05)
Active Ingredients:
- Sincalide
Dosage Strength:
- 5 ug/5mL
Pharmaceutical Classes:
- Cholecystokinin Analog [EPC]
- Cholecystokinin [CS]
Related Products:
Based on records with the same trade name.- 51808-203 Sincalide 3 ug/1 Intravenous Injection, Powder, Lyophilized, for Solution by Anazaohealth Corporation
- 63323-579 Sincalide 5 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
- 72266-248 Sincalide 5 ug/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Fosun Pharma USA Inc
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 70511-124Next: 70511-141 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.